StonvexLoading…
StonvexStonvexStonvexCore line items from TSPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $307.00K | $307.00K | $215.00K | $9.37M |
Operating Income | $-248.63M | $-177.98M | $-90.58M | $-489.06M |
Net Income | $-220.69M | $-78.04M | $-81.21M | $-472.05M |
EPS (Diluted) | $-0.97 | $-0.70 | $-0.36 | $-2.11 |
Total Assets | $848.49M | $909.63M | $986.93M | $1.07B |
Total Liabilities | $77.12M | $89.48M | $95.54M | $119.80M |
Cash & Equivalents | $249.21M | $314.71M | $510.01M | $615.39M |
Free Cash Flow OCF − CapEx | Not available | $-158.77M | $-88.36M | $-343.47M |
Shares Outstanding | 227.99M | 227.20M | 226.41M | 224.16M |